Perceptive Advisors as of Sept. 30, 2024
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 106 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arcellx Common Stock (ACLX) | 6.9 | $325M | 3.9M | 83.51 | |
| Nuvalent Inc-a (NUVL) | 6.4 | $305M | 3.0M | 102.30 | |
| Amicus Therapeutics (FOLD) | 6.3 | $300M | 28M | 10.68 | |
| Iovance Biotherapeutics (IOVA) | 5.3 | $250M | 27M | 9.39 | |
| Vaxcyte (PCVX) | 4.9 | $232M | 2.0M | 114.27 | |
| Verona Pharma Sponsored Ads (VRNA) | 4.1 | $196M | 6.8M | 28.77 | |
| Rhythm Pharmaceuticals (RYTM) | 3.9 | $187M | 3.6M | 52.39 | |
| Soleno Therapeutics (SLNO) | 3.4 | $162M | 3.2M | 50.49 | |
| Intra Cellular Therapies (ITCI) | 2.5 | $119M | 1.6M | 73.17 | |
| Apogee Therapeutics (APGE) | 2.5 | $118M | 2.0M | 58.74 | |
| Viking Therapeutics (VKTX) | 2.3 | $108M | 1.7M | 63.31 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 2.1 | $101M | 6.3M | 15.99 | |
| Immatics SHS (IMTX) | 2.0 | $92M | 8.1M | 11.41 | |
| Evolus (EOLS) | 1.8 | $87M | 5.4M | 16.20 | |
| Spyre Therapeutics Com New (SYRE) | 1.8 | $85M | 2.9M | 29.41 | |
| CryoLife (AORT) | 1.6 | $74M | 2.8M | 26.62 | |
| Biohaven (BHVN) | 1.6 | $74M | 1.5M | 49.97 | |
| Astria Therapeutics (ATXS) | 1.5 | $71M | 6.5M | 11.01 | |
| Axsome Therapeutics (AXSM) | 1.5 | $70M | 783k | 89.87 | |
| Applied Therapeutics (APLT) | 1.4 | $68M | 8.0M | 8.50 | |
| Cargo Therapeutics (CRGX) | 1.4 | $68M | 3.7M | 18.45 | |
| Immunovant (IMVT) | 1.4 | $68M | 2.4M | 28.51 | |
| Praxis Precision Medicines I Com New (PRAX) | 1.4 | $67M | 1.2M | 57.54 | |
| Argenx Se Sponsored Adr (ARGX) | 1.4 | $64M | 119k | 542.08 | |
| Miragen Therapeutics (VRDN) | 1.4 | $64M | 2.8M | 22.75 | |
| Edgewise Therapeutics (EWTX) | 1.3 | $62M | 2.3M | 26.69 | |
| Protagonist Therapeutics (PTGX) | 1.3 | $62M | 1.4M | 45.00 | |
| Meiragtx Holdings (MGTX) | 1.1 | $52M | 13M | 4.17 | |
| Aldeyra Therapeutics (ALDX) | 1.1 | $50M | 9.3M | 5.39 | |
| Akero Therapeutics (AKRO) | 1.0 | $49M | 1.7M | 28.69 | |
| Solid Biosciences Com New (SLDB) | 1.0 | $48M | 6.9M | 6.97 | |
| Tarsus Pharmaceuticals (TARS) | 0.9 | $43M | 1.3M | 32.89 | |
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 0.8 | $40M | 400k | 98.80 | |
| Acrivon Therapeutics Common Stock (ACRV) | 0.8 | $38M | 5.4M | 7.00 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.8 | $37M | 725k | 51.10 | |
| Nautilus Biotechnology (NAUT) | 0.8 | $36M | 13M | 2.85 | |
| Celcuity (CELC) | 0.7 | $35M | 2.4M | 14.91 | |
| Insulet Corporation (PODD) | 0.7 | $33M | 142k | 232.75 | |
| Oruka Therapeutics (ORKA) | 0.6 | $30M | 1.2M | 24.51 | |
| Contineum Therapeutics Cl A (CTNM) | 0.6 | $29M | 1.5M | 19.14 | |
| Ocular Therapeutix (OCUL) | 0.6 | $29M | 3.3M | 8.70 | |
| Intuitive Surgical Com New (ISRG) | 0.6 | $29M | 58k | 491.27 | |
| Natera (NTRA) | 0.6 | $28M | 220k | 126.95 | |
| Cg Oncology (CGON) | 0.6 | $28M | 734k | 37.73 | |
| Zymeworks Del (ZYME) | 0.6 | $27M | 2.2M | 12.55 | |
| Dyne Therapeutics (DYN) | 0.5 | $26M | 718k | 35.92 | |
| Adagio Med Hldgs (ADGM) | 0.5 | $25M | 9.8M | 2.58 | |
| Arvinas Ord (ARVN) | 0.5 | $25M | 1.0M | 24.63 | |
| Procept Biorobotics Corp (PRCT) | 0.5 | $25M | 316k | 80.12 | |
| Neurocrine Biosciences (NBIX) | 0.5 | $25M | 212k | 115.22 | |
| Health Sciences Acq Corp 2 (OBIO) | 0.5 | $24M | 4.6M | 5.14 | |
| Instil Bio Com New (TIL) | 0.5 | $23M | 346k | 67.32 | |
| Livanova SHS (LIVN) | 0.5 | $23M | 429k | 52.54 | |
| Springworks Therapeutics (SWTX) | 0.5 | $22M | 692k | 32.04 | |
| Medtronic SHS (MDT) | 0.5 | $22M | 245k | 90.03 | |
| Adma Biologics (ADMA) | 0.4 | $21M | 1.1M | 19.99 | |
| Xenon Pharmaceuticals (XENE) | 0.4 | $21M | 525k | 39.37 | |
| Zenas Biopharma (ZBIO) | 0.4 | $19M | 1.1M | 16.92 | |
| Disc Medicine (IRON) | 0.4 | $19M | 387k | 49.14 | |
| Rocket Pharmaceuticals (RCKT) | 0.4 | $17M | 932k | 18.47 | |
| Inhibrx Biosciences (INBX) | 0.4 | $17M | 1.1M | 15.66 | |
| Rapport Therapeutics (RAPP) | 0.3 | $15M | 748k | 20.48 | |
| Merus N V (MRUS) | 0.3 | $15M | 300k | 49.96 | |
| Insmed Com Par $.01 (INSM) | 0.3 | $13M | 180k | 73.00 | |
| Icon SHS (ICLR) | 0.3 | $13M | 44k | 287.31 | |
| Arcutis Biotherapeutics (ARQT) | 0.3 | $13M | 1.4M | 9.30 | |
| Pepgen (PEPG) | 0.3 | $12M | 1.4M | 8.55 | |
| Tyra Biosciences (TYRA) | 0.3 | $12M | 511k | 23.51 | |
| Xencor (XNCR) | 0.2 | $11M | 528k | 20.11 | |
| Verrica Pharmaceuticals | 0.2 | $10M | 7.1M | 1.45 | |
| Roivant Sciences SHS (ROIV) | 0.2 | $9.8M | 848k | 11.54 | |
| Arrivent Biopharma (AVBP) | 0.2 | $9.8M | 415k | 23.50 | |
| EXACT Sciences Corporation (EXAS) | 0.2 | $8.5M | 125k | 68.12 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.2 | $8.3M | 1.0M | 7.99 | |
| Allogene Therapeutics (ALLO) | 0.2 | $7.6M | 2.7M | 2.80 | |
| Amylyx Pharmaceuticals (AMLX) | 0.1 | $6.9M | 2.1M | 3.24 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.1 | $5.8M | 256k | 22.63 | |
| Female Health (VERU) | 0.1 | $5.6M | 7.3M | 0.77 | |
| Cassava Sciences Put Option (SAVA) | 0.1 | $5.4M | 183k | 29.43 | |
| Fulcrum Therapeutics Call Option (FULC) | 0.1 | $5.4M | 1.5M | 3.57 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 0.1 | $5.2M | 500k | 10.45 | |
| Biodesix (BDSX) | 0.1 | $3.9M | 2.2M | 1.78 | |
| Precision Biosciences Com New (DTIL) | 0.1 | $3.8M | 426k | 8.96 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.1 | $3.4M | 816k | 4.11 | |
| Lyra Therapeutics | 0.1 | $3.3M | 13M | 0.26 | |
| Nanobiotix Sponsored Ads (NBTX) | 0.1 | $3.2M | 555k | 5.75 | |
| Absci Corp (ABSI) | 0.1 | $2.7M | 700k | 3.82 | |
| Athira Pharma (ATHA) | 0.1 | $2.4M | 5.4M | 0.45 | |
| X4 Pharmaceuticals | 0.1 | $2.4M | 3.5M | 0.67 | |
| Envveno Medical (NVNO) | 0.0 | $2.3M | 694k | 3.36 | |
| Kymera Therapeutics (KYMR) | 0.0 | $2.2M | 46k | 47.33 | |
| Trinity Biotech Spons Adr New (TRIB) | 0.0 | $2.0M | 1.8M | 1.10 | |
| Pyxis Oncology Common Stock (PYXS) | 0.0 | $1.9M | 509k | 3.67 | |
| Irhythm Technologies (IRTC) | 0.0 | $1.7M | 23k | 74.24 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.0 | $1.5M | 35k | 43.89 | |
| Lexeo Therapeutics (LXEO) | 0.0 | $1.3M | 140k | 9.04 | |
| Novavax Com New Put Option (NVAX) | 0.0 | $1.3M | 100k | 12.63 | |
| Fate Therapeutics (FATE) | 0.0 | $1.2M | 346k | 3.50 | |
| Singular Genomics Systems In Com New | 0.0 | $798k | 51k | 15.67 | |
| Kyverna Therapeutics (KYTX) | 0.0 | $734k | 150k | 4.89 | |
| Forte Biosciences Com New (FBRX) | 0.0 | $535k | 96k | 5.59 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.0 | $251k | 117k | 2.15 | |
| Caremax Cl A New | 0.0 | $170k | 100k | 1.70 | |
| Revolution Medicines *w Exp 12/17/202 (RVMDW) | 0.0 | $35k | 250k | 0.14 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $1.7k | 167k | 0.01 | |
| Caremax *w Exp 06/08/202 | 0.0 | $594.000000 | 60k | 0.01 |
